Compound 1060
Identifiers
- Canonical SMILES:
Fc1ccc(cc1)-n1[nH]c2c3ccsc3nc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C21H11F4N3OS/c22-13-4-6-14(7-5-13)28-20(29)16-17(11-2-1-3-12(10-11)21(23,24)25)26-19-15(8-9-30-19)18(16)27-28/h1-10,27H
- InChiKey:
QPWYDVZRXMIKKO-UHFFFAOYSA-N
External links
11683381 |
9858109 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.22 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 429.06 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 6.56 | |||
TPSA | 45.23 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4770 | 6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one | DB07628 | |
0.4280 | MK-0249 | DB11910 | |
0.4273 | CP-94707 | DB07578 | |
0.4153 | Ravoxertinib | DB15281 | |
0.4143 | Dilmapimod | DB12140 | |
0.4108 | Sufugolix | DB06494 | |
0.4101 | ABT-288 | DB15192 | |
0.4071 | Tepotinib | DB15133 | |
0.4029 | Relugolix | DB11853 | |
0.4029 | Merestinib | DB12381 | |
0.4025 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4023 | 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE | DB08788 | |
0.4008 | Lorecivivint | DB14883 | |
0.3926 | Zopolrestat | DB08772 | |
0.3891 | AT-001 | DB15121 |